Further results suggested that Mpc1 loss and upregulated glycolysis led to an increased frequency of Apc loss of heterozygosity, the crucial genetic tumorigenic alteration in this model, thereby promoting further mutational events facilitating the shift from a benign adenoma into an invasive adenocarcinoma. The gene discussed is APC; the disease is adenoma.